{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:36:27Z","timestamp":1761237387729},"reference-count":152,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Failure Clinics"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.hfc.2004.10.003","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T15:27:03Z","timestamp":1168442823000},"page":"77-93","source":"Crossref","is-referenced-by-count":3,"title":["Role of Neurohormonal Modulators in Heart Failure with Relatively Preserved Systolic Function"],"prefix":"10.1016","volume":"1","author":[{"given":"Jonathan A.","family":"Rapp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihai","family":"Gheorghiade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hfc.2004.10.003_bib1","series-title":"Heart disease and stroke statistics\u20142004 update","year":"2003"},{"key":"10.1016\/j.hfc.2004.10.003_bib2","series-title":"2002 heart and stroke statistical update","year":"2003"},{"key":"10.1016\/j.hfc.2004.10.003_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0733-8651(05)70242-3","article-title":"Epidemiology of heart failure","volume":"19","author":"Miller","year":"2001","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.hfc.2004.10.003_bib4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1053\/hj.1999.v137.95495","article-title":"Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995","volume":"137","author":"Haldeman","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2003.07.046","article-title":"Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics, and prognosis","volume":"43","author":"Hogg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib6","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0002-9149(01)01568-5","article-title":"Prevalence of heart failure in Asturias (a region in the north of Spain)","volume":"87","author":"Cortina","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib7","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/euhj.1998.1239","article-title":"Prevalence of heart failure and left ventricular dysfunction in the general population: the Rotterdam Study","volume":"20","author":"Mosterd","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1136\/heart.86.2.172","article-title":"Cross-sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk","volume":"86","author":"Nielsen","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2004.10.003_bib9","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/euhj.2000.2284","article-title":"Left ventricular systolic dysfunction in 75-year-old men and women; a population-based study","volume":"22","author":"Hedberg","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/bmj.318.7180.368","article-title":"Prevalence and clinical characteristics of left ventricular dysfunction among elderly patients in general practice setting: cross-sectional survey","volume":"318","author":"Morgan","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.hfc.2004.10.003_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2796.1997.129150000.x","article-title":"Congestive heart failure in old age: prevalence, mechanisms and 4-year prognosis in the Helsinki Ageing Study","volume":"241","author":"Kupari","year":"1997","journal-title":"J Intern Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib12","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1388-9842(02)00034-X","article-title":"Prevalence of chronic heart failure in Southwestern Europe: the EPICA study","volume":"4","author":"Ceia","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2004.10.003_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0002-9149(00)01393-X","article-title":"Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study","volume":"87","author":"Kitzman","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib14","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0002-9149(00)01165-6","article-title":"Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study","volume":"86","author":"Devereux","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2004.10.003_bib16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0735-1097(95)00381-9","article-title":"Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective","volume":"26","author":"Vasan","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0735-1097(03)00185-2","article-title":"Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline","volume":"41","author":"Smith","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 7","key":"10.1016\/j.hfc.2004.10.003_bib18","first-page":"S21","article-title":"The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure","volume":"4","year":"2003","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib19","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"McKee","year":"1971","journal-title":"N Engl J Med"},{"issue":"5A","key":"10.1016\/j.hfc.2004.10.003_bib21","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1016\/j.amjmed.2003.10.021","article-title":"New insights into diastolic heart failure: role of diabetes mellitus","volume":"116","author":"Piccini","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib22","first-page":"2018","article-title":"Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing not Properly Multinational Study","volume":"41","author":"Maisel","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib23","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/hc1102.105289","article-title":"New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib24","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa032566","article-title":"Diastolic heart failure\u2014abnormalities in active relaxation and passive stiffness of the left ventricle","volume":"350","author":"Zile","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib25","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0735-1097(03)00186-4","article-title":"Heart failure with preserved ejection fraction: is this diastolic heart failure?","volume":"41","author":"Zile","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib26","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/euhj.1998.1057","article-title":"How to diagnose diastolic heart failure","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib27","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1161\/01.CIR.101.17.2118","article-title":"Defining diastolic heart failure: a call for standardized diagnostic criteria","volume":"101","author":"Vasan","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM200101043440103","article-title":"The pathogenesis of acute pulmonary edema associated with hypertension","volume":"344","author":"Gandhi","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib29","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib30","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1001\/jama.288.17.2144","article-title":"Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure","volume":"288","author":"Kitzman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2004.10.003_bib31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1054\/jcaf.2002.128871","article-title":"Diastolic heart failure in the community: clinical profile, natural history, therapy, and impact of proposed diagnostic criteria","volume":"8","author":"Chen","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.hfc.2004.10.003_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0002-9343(99)80250-2","article-title":"Hospitalized congestive heart failure patients with preserved versus abnormal left ventricular systolic function: clinical characteristics and drug therapy","volume":"99","author":"McDermott","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0002-9343(00)00601-X","article-title":"Systolic versus diastolic heart failure in the community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors","volume":"109","author":"Philbin","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib34","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0002-9149(96)00719-9","article-title":"Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction","volume":"79","author":"Pernenkil","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib35","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0002-8703(97)70057-7","article-title":"Systolic function, readmission rates, and survival among consecutively hospitalized patients with congestive heart failure","volume":"134","author":"McDermott","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib36","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0735-1097(99)00118-7","article-title":"Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort","volume":"33","author":"Vasan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0002-8703(99)70251-6","article-title":"Insights into the contemporary epidemiology and outpatient management of congestive heart failure","volume":"138","author":"McAlister","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib38","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1161\/01.CIR.98.21.2282","article-title":"Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991","volume":"98","author":"Senni","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib39","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0735-1097(01)01442-5","article-title":"Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG Study","volume":"38","author":"Rich","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib40","first-page":"656","article-title":"Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists: data from the Italian Network on Congestive Heart Failure","volume":"3","author":"Tarantini","year":"2002","journal-title":"Ital Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0735-1097(91)90589-2","article-title":"Congestive heart failure symptoms in patients with preserved left ventricular systolic function: analysis of the CASS registry","volume":"18","author":"Judge","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib43","doi-asserted-by":"crossref","first-page":"502","DOI":"10.7326\/0003-4819-117-6-502","article-title":"Left ventricular diastolic dysfunction as a cause of congestive heart failure: mechanisms and management","volume":"117","author":"Bonow","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib44","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9149(70)90787-3","article-title":"The shape and movements of the human left ventricle during systole: a study by cineangiography and by cineradiography of epicardial markers","volume":"26","author":"McDonald","year":"1970","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib45","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/01.CIR.52.5.859","article-title":"Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers","volume":"52","author":"Ingels","year":"1975","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib46","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/S0002-9149(98)00222-7","article-title":"Left ventricular systolic torsion and early diastolic filling by echocardiography in normal humans","volume":"81","author":"Rothfeld","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib47","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1067\/mje.2001.114843","article-title":"Noncircumferential myofiber function: impact on early diastolic filling in children","volume":"14","author":"Michelfelder","year":"2001","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.hfc.2004.10.003_bib48","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1161\/01.CIR.85.4.1572","article-title":"Dissociation between left ventricular untwisting and filling: accentuation by catecholamines","volume":"85","author":"Rademakers","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib49","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/01.CIR.82.4.1174","article-title":"Minimum left ventricular pressure during beta-adrenergic stimulation in human subjects: evidence for elastic recoil and diastolic \u201csuction\u201d in the normal heart","volume":"82","author":"Udelson","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib50","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/hc1202.105290","article-title":"New concepts in diastolic dysfunction and diastolic heart failure II. Causal mechanisms and treatment","volume":"105","author":"Zile","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib51","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0022-2828(79)90381-X","article-title":"Hypoxia and calcium","volume":"11","author":"Nayler","year":"1979","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib52","first-page":"H677","article-title":"Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart","volume":"233","author":"Henry","year":"1977","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib53","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1172\/JCI107713","article-title":"Incomplete relaxation between beats after myocardial hypoxia and ischemia","volume":"53","author":"Weisfeldt","year":"1974","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2004.10.003_bib54","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1152\/ajplegacy.1973.224.3.497","article-title":"Mitochondria and sarcoplasmic reticulum function in cardiac hypertrophy and failure","volume":"224","author":"Sordahl","year":"1973","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-2828(74)90053-4","article-title":"Intracellular calcium and myocardial contractility. V. Calcium uptake of sarcoplasmic reticulum fractions in hypertrophied and failing rabbit hearts","volume":"6","author":"Ito","year":"1974","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1161\/01.RES.61.1.70","article-title":"Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure","volume":"61","author":"Gwathmey","year":"1987","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib57","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.RES.87.3.235","article-title":"Alterations in the determinants of diastolic suction during pacing tachycardia","volume":"87","author":"Bell","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/01.RES.86.1.59","article-title":"Differential expression of cardiac titin isoforms and modulation of cellular stiffness","volume":"86","author":"Cazorla","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib59","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/01.RES.64.6.1041","article-title":"Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle","volume":"64","author":"Jalil","year":"1989","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib60","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1016\/0002-9149(90)90952-W","article-title":"Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension","volume":"65","author":"Weber","year":"1990","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib61","first-page":"H863","article-title":"Inhibition of collagen cross-linking: effects on fibrillar collagen and ventricular diastolic function","volume":"269","author":"Kato","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib62","doi-asserted-by":"crossref","first-page":"18D","DOI":"10.1016\/S0002-9149(99)80487-1","article-title":"The cardiac renin-angiotensin-aldosterone system and hypertensive cardiac hypertrophy","volume":"76","author":"Raman","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib63","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archinte.1993.00410080011002","article-title":"Tissue renin-angiotensin system in myocardial hypertrophy and failure","volume":"153","author":"Dzau","year":"1993","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib64","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI114924","article-title":"Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation","volume":"86","author":"Schunkert","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2004.10.003_bib65","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1161\/01.RES.70.5.931","article-title":"Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy: modification by specific inhibition of cardiac angiotensin converting enzyme","volume":"70","author":"Eberli","year":"1992","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib66","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1172\/JCI115611","article-title":"Exacerbation of ischemic dysfunction by angiotensin II in red cell-perfused rabbit hearts: Effects of coronary flow, contractility, and high-energy phosphate metabolism","volume":"89","author":"Mochizuki","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hfc.2004.10.003_bib67","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1210\/jc.82.5.1345","article-title":"Tissue-specific expression of alpha and beta messenger ribonucleic acid isoforms of the human mineralocorticoid receptor in normal and pathological states","volume":"82","author":"Zennaro","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.hfc.2004.10.003_bib68","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.HYP.19.3.221","article-title":"Aldosterone regulation of gene transcription leading to control of ion transport","volume":"19","author":"Horisberger","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2004.10.003_bib70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.24.1.30","article-title":"Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension","volume":"24","author":"Robert","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2004.10.003_bib71","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.carrad.2004.06.004","article-title":"The role of aldosterone and aldosterone-receptor antagonists in heart failure","volume":"5","author":"Khan","year":"2004","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib72","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1161\/01.RES.62.5.953","article-title":"Microvascular changes in the heart during chronic arterial hypertension","volume":"62","author":"Laine","year":"1988","journal-title":"Circ Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib73","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/clpt.1994.176","article-title":"Aging and cardiovascular responsiveness to beta-agonist in humans: role of changes in beta-receptor responses versus baroreflex activity","volume":"56","author":"White","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.hfc.2004.10.003_bib74","first-page":"H927","article-title":"Myocardial aging: functional alterations and related cellular mechanisms","volume":"242","author":"Lakatta","year":"1982","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib75","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0735-1097(01)01452-8","article-title":"Diastolic heart failure, diastolic left ventricular dysfunction and exercise intolerance","volume":"38","author":"O'Rourke","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib76","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/01.CIR.99.17.2261","article-title":"Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism","volume":"99","author":"Lamb","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib77","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/01.CIR.92.4.1011","article-title":"Bioenergetic consequences of left ventricular remodeling","volume":"92","author":"Zhang","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib78","doi-asserted-by":"crossref","first-page":"C980","DOI":"10.1152\/ajpcell.1992.262.4.C980","article-title":"Relaxation abnormalities in single cardiac myocytes from renovascular hypertensive rats","volume":"262","author":"Yelamarty","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib79","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0008-6363(99)00099-1","article-title":"Afterload induced changes in myocardial relaxation: a mechanism for diastolic dysfunction","volume":"43","author":"Leite-Moreira","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib80","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","article-title":"Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro","volume":"75","author":"Sadoshima","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.hfc.2004.10.003_bib81","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1749-6632.1995.tb17443.x","article-title":"Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes","volume":"752","author":"Van Heugten","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.hfc.2004.10.003_bib82","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0002-8703(99)70416-3","article-title":"Longitudinal changes and prognostic implications of left ventricular diastolic function in first acute myocardial infarction","volume":"137","author":"Poulsen","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib83","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/hrt.78.6.564","article-title":"Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients","volume":"78","author":"Pardaens","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2004.10.003_bib84","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","article-title":"Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study","volume":"35","author":"Gottdiener","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib85","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1067\/mhj.2002.126446","article-title":"The relevance of subgroup-specific treatment effects: the Studies of Left Ventricular Dysfunction (SOLVD) revisited","volume":"144","author":"Parker","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib86","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.CIR.0000054165.93055.42","article-title":"Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study","volume":"107","author":"Arnold","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib87","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1136\/bmj.1.6074.1444","article-title":"Diabetic cardiomyopathy: the preclinical phase","volume":"1","author":"Seneviratne","year":"1977","journal-title":"BMJ"},{"key":"10.1016\/j.hfc.2004.10.003_bib88","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diacare.17.7.633","article-title":"Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy?: an echocardiographic study of young type I diabetic patients","volume":"17","author":"Raev","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hfc.2004.10.003_bib89","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-9149(00)01366-7","article-title":"Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus","volume":"87","author":"Zabalgoitia","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib90","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0735-1097(01)01230-X","article-title":"The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study","volume":"37","author":"Liu","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.0954-6820.1983.tb03752.x","article-title":"Effect of correction of hyperglycemia on left ventricular function in non-insulin-dependent (type 2) diabetics","volume":"213","author":"Uusitupa","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.hfc.2004.10.003_bib92","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00019501-199602000-00002","article-title":"The myocardial and vascular pathology of diabetic cardiomyopathy","volume":"7","author":"Hardin","year":"1996","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.hfc.2004.10.003_bib93","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/01.CIR.0000012467.61045.87","article-title":"Adaptation and maladaptation of the heart in diabetes. II. Potential mechanisms","volume":"105","author":"Young","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00925676","article-title":"Modification of myosin isozymes and SR Ca(2 +)-pump ATPase of the diabetic rat heart by lipid-lowering interventions","volume":"132","author":"Rupp","year":"1994","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.hfc.2004.10.003_bib95","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0140-6736(98)90311-7","article-title":"Why does the myocardium fail?: insights from basic science","volume":"352","author":"Bristow","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib96","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1006\/jmcc.2000.1139","article-title":"Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction","volume":"32","author":"Depre","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1023\/A:1006950218597","article-title":"Differential changes in cardiac myofibrillar and sarcoplasmic reticular gene expression in alloxan-induced diabetes","volume":"200","author":"Golfman","year":"1999","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.hfc.2004.10.003_bib98","first-page":"H192","article-title":"Mitochondrial dysfunction accompanies diastolic dysfunction in diabetic rat heart","volume":"271","author":"Flarsheim","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib99","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(00)03149-4","article-title":"Etomoxir: a new approach to treatment of chronic heart failure","volume":"356","author":"Bristow","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib100","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic HF and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib101","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","article-title":"Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2004.10.003_bib102","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib103","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1161\/01.CIR.90.4.2056","article-title":"Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection","volume":"90","author":"Lonn","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib104","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1161\/01.CIR.101.12.1372","article-title":"Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability","volume":"101","author":"Schieffer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib105","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","article-title":"Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib106","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/01.CIR.100.4.376","article-title":"Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction","volume":"100","author":"Pedersen","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib107","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1161\/01.CIR.0000072793.81076.D4","article-title":"Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials","volume":"10","author":"Vermes","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib108","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(98)05012-0","article-title":"Effect of angiotensin-converting- enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial","volume":"353","author":"Hansson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib109","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/01.CIR.0000091405.00772.6E","article-title":"Effects of eplerenone, enalapril, and eplerenone\/enalapril in patients with essential hypertension and left ventricular hypertrophy. The 4E-left ventricular hypertrophy study","volume":"108","author":"Pitt","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib110","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisionpril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib111","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib112","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib113","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","article-title":"The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial","volume":"21","author":"Lithell","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2004.10.003_bib114","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/01.CIR.0000022665.18619.83","article-title":"Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study","volume":"106","author":"Madrid","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib115","doi-asserted-by":"crossref","first-page":"15A","DOI":"10.1016\/S0895-7061(02)02312-9","article-title":"Regression of hypertensive left ventricular hypertrophy by angiotensin receptor blockade versus beta-blockade: the LIFE trial (abstract)","volume":"15","author":"Devereux","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hfc.2004.10.003_bib116","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/bmj.293.6555.1145","article-title":"Randomised trial of treatment of hypertension in elderly patients in primary care","volume":"293","author":"Coope","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.hfc.2004.10.003_bib117","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1097\/00004872-199210120-00013","article-title":"Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: a report from the STOP-Hypertension study","volume":"10","author":"Ekbom","year":"1992","journal-title":"J Hypertens"},{"key":"10.1016\/j.hfc.2004.10.003_bib118","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.304.6824.405","article-title":"Medical Research Council trial of treatment of hypertension in older adults: principal results","volume":"304","year":"1992","journal-title":"BMJ"},{"issue":"Suppl","key":"10.1016\/j.hfc.2004.10.003_bib119","doi-asserted-by":"crossref","first-page":"7B","DOI":"10.1016\/j.amjcard.2004.01.020","article-title":"Beta-blockers in hypertension: is carvedilol different?","volume":"93","author":"Messerli","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM198104023041401","article-title":"Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction","volume":"304","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib121","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction: I. Mortality results","volume":"247","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2004.10.003_bib122","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1001\/jama.1983.03340200048027","article-title":"A randomized trial of propranolol in patients with acute myocardial infarction: II. Morbidity results","volume":"250","year":"1983","journal-title":"JAMA"},{"key":"10.1016\/j.hfc.2004.10.003_bib123","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0735-1097(96)00489-5","article-title":"Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators","volume":"29","author":"Vantrimpont","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib124","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/hrt.81.1.25","article-title":"Beta-blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study","volume":"81","author":"Spargias","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.hfc.2004.10.003_bib125","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib126","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.jacc.2003.11.032","article-title":"The Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study approaches to control rate in atrial fibrillation","volume":"43","author":"Olshansky","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib127","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0735-1097(00)00693-8","article-title":"Use of metoprolol CR\/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study","volume":"36","author":"Kuhlkamp","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib128","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ndt\/13.3.564","article-title":"Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)","volume":"13","author":"Schmieder","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.hfc.2004.10.003_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-8703(03)00525-8","article-title":"Effects of carvedilol therapy on restrictive diastolic filling pattern in chronic heart failure","volume":"147","author":"Palazzuoli","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib130","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0002-8703(00)90036-X","article-title":"Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol","volume":"139","author":"Capomolla","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib131","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ejheart.2004.02.003","article-title":"Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC)","volume":"6","author":"Bergstrom","year":"2004","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hfc.2004.10.003_bib132","first-page":"915","article-title":"Eplerenone (Inspra) for hypertension","volume":"69","author":"Taylor","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.hfc.2004.10.003_bib133","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.amjcard.2004.01.007","article-title":"Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension","volume":"93","author":"Williams","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib134","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000067463.13172.EA","article-title":"Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension","volume":"41","author":"White","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2004.10.003_bib135","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0735-1097(03)00054-8","article-title":"Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients","volume":"41","author":"Flack","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib136","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.hfc.2004.10.003_bib137","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","article-title":"Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients","volume":"19","author":"Duprez","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hfc.2004.10.003_bib138","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0735-1097(01)01729-6","article-title":"Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression","volume":"39","author":"Bauersachs","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib139","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","article-title":"Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension","volume":"71","author":"Brilla","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib140","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmcc.1993.1066","article-title":"Anti-aldosterone treatment and prevention of myocardial fibrosis in primary and secondary hyperaldosteronism","volume":"25","author":"Brilla","year":"1993","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib141","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0735-1097(00)01129-3","article-title":"Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats","volume":"37","author":"Lacolley","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hfc.2004.10.003_bib142","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib143","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1161\/01.CIR.101.14.1729","article-title":"Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease","volume":"101","author":"Querejeta","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib144","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0895-7061(97)91058-X","article-title":"Effects of the selective mineralocorticoid receptor antagonist, eplerenone, in a model of aldosterone-induced hypertension and cardiac fibrosis [abstract]","volume":"11","author":"Frierdich","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.hfc.2004.10.003_bib145","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.hfc.2004.10.003_bib146","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cardiores.2003.11.037","article-title":"Review of aldosterone- and angiotensin II-induced target organ damage and prevention","volume":"61","author":"Struthers","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hfc.2004.10.003_bib147","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib148","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib149","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.hfc.2004.10.003_bib150","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib151","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hfc.2004.10.003_bib152","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"}],"container-title":["Heart Failure Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713604000042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551713604000042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T17:17:29Z","timestamp":1556039849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551713604000042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":152,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1551713604000042"],"URL":"https:\/\/doi.org\/10.1016\/j.hfc.2004.10.003","relation":{},"ISSN":["1551-7136"],"issn-type":[{"value":"1551-7136","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}